Novartis
NVS
#55
Rank
โ‚ฌ218.02 B
Marketcap
113,62ย โ‚ฌ
Share price
-0.96%
Change (1 day)
21.67%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

Market capitalization of Novartis (NVS)

Market cap: โ‚ฌ218.02 Billion

As of December 2025 Novartis has a market cap of โ‚ฌ218.02 Billion. This makes Novartis the world's 55th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novartis from 1998 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ218.02 B15.34%
2024โ‚ฌ189.03 B0.69%
2023โ‚ฌ187.74 B3.2%
2022โ‚ฌ181.91 B4.86%
2021โ‚ฌ173.48 B-2.02%
2020โ‚ฌ177.05 B-7.68%
2019โ‚ฌ191.77 B11.21%
2018โ‚ฌ172.44 B4.93%
2017โ‚ฌ164.34 B-0.07%
2016โ‚ฌ164.45 B-13.74%
2015โ‚ฌ190.65 B3.51%
2014โ‚ฌ184.19 B30.69%
2013โ‚ฌ140.94 B22.39%
2012โ‚ฌ115.16 B8.3%
2011โ‚ฌ106.33 B5.09%
2010โ‚ฌ101.18 B15.94%
2009โ‚ฌ87.27 B8.26%
2008โ‚ฌ80.61 B-4.29%
2007โ‚ฌ84.22 B-17.6%
2006โ‚ฌ102.22 B-1.22%
2005โ‚ฌ103.48 B14.45%
2004โ‚ฌ90.41 B0.52%
2003โ‚ฌ89.94 B3.43%
2002โ‚ฌ86.96 B-17.43%
2001โ‚ฌ105.31 B-14.95%
2000โ‚ฌ123.82 B29.61%
1999โ‚ฌ95.53 B-15.54%
1998โ‚ฌ113.10 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Novartis was reported to be:

โ‚ฌ224.41 Billion
by Nasdaq info icon info icon
โ‚ฌ218.02 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
โ‚ฌ216.21 B-0.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ125.37 B-42.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ418.56 B 91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ102.41 B-53.03%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
โ‚ฌ84.11 B-61.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ27.96 B-87.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
โ‚ฌ90.73 B-58.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ187.26 B-14.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ239.50 B 9.85%๐Ÿ‡ฌ๐Ÿ‡ง UK